IRIS
DI PASQUA, LAURA GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.327
EU - Europa 741
AS - Asia 363
AF - Africa 3
SA - Sud America 1
Totale 2.435
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.315
IE - Irlanda 412
CN - Cina 333
FI - Finlandia 79
DE - Germania 73
IT - Italia 63
SE - Svezia 28
UA - Ucraina 28
BE - Belgio 27
JP - Giappone 20
CZ - Repubblica Ceca 16
CA - Canada 12
GB - Regno Unito 11
IN - India 4
FR - Francia 3
SG - Singapore 3
EG - Egitto 2
BR - Brasile 1
IR - Iran 1
KR - Corea 1
MU - Mauritius 1
PH - Filippine 1
RO - Romania 1
Totale 2.435
Salva come PNG Salva come JPEG
Città #
Chandler 455
Dublin 410
Beijing 78
Ashburn 73
Shanghai 66
Princeton 65
Helsinki 63
Lawrence 63
Medford 61
Jacksonville 49
Nanjing 49
Wilmington 44
Ann Arbor 38
Pavia 37
Brussels 27
Hebei 25
Changsha 20
Nanchang 20
Tokyo 20
Munich 16
Hangzhou 13
New York 13
Shenyang 13
Brno 12
Toronto 12
Jiaxing 11
Boardman 10
Seattle 9
Los Angeles 8
Tianjin 8
Berlin 7
Des Moines 7
Fairfield 7
Falls Church 7
Houston 6
Raleigh 5
Redwood City 5
Washington 5
Brdo 4
Cagliari 4
Dearborn 4
Guangzhou 4
Laurel 4
Alexandria 3
Brescia 3
Chicago 3
Singapore 3
Verona 3
Andover 2
Florence 2
Fuzhou 2
Menlo Park 2
Ningbo 2
Orange 2
Pune 2
Rockville 2
Shenzhen 2
Woodbridge 2
Bovisio Masciago 1
Cambridge 1
Cesena 1
Clearwater 1
Dalian 1
Falkenstein 1
Frankfurt am Main 1
General Trias 1
Giussano 1
Gunzenhausen 1
Jinan 1
Leawood 1
Littleton 1
Melegnano 1
Milan 1
Qingdao 1
Qujing 1
Rome 1
San Francisco 1
Southend 1
Tangjin 1
Timisoara 1
Urbandale 1
Venegono Superiore 1
Verrua Po 1
Wuhan 1
Zelo Buon Persico 1
Totale 1.919
Salva come PNG Salva come JPEG
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 102
Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress 86
Metabolic shift in liver: correlation between perfusion temperature and hypoxia inducible factor-1α. 76
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 55
Immobilized amyloid Aβ peptides support platelet adhesion and activation 54
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 54
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 54
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 53
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 52
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 52
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 52
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 52
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 51
Fluorescing fatty acids in rat fatty liver models 48
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 48
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 47
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 46
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 45
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 45
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 44
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 42
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 41
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 40
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 38
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 38
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 37
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 37
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 37
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 36
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 35
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 35
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 33
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 33
Liver injury and changes in biliary, tissue and serum levels of Asymmetric Dimethylarginine: role of Obeticholic Acid, a Farnesoid X Receptor agonist. 32
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 32
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 32
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 32
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 32
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 31
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 31
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 30
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 30
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 30
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 29
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 28
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 28
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 28
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 28
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 28
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH 27
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 27
Fluorescence excitation properties of bilirubin in solution and in serum 27
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 27
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 26
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 25
Autofluorescence detection of liver oxidative damage products 25
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 24
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 24
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 23
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 22
Changes in glutathione content in liver diseases: An update 22
MPEP administration reduces steatosis and inflammation in ob/ob mice 20
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 18
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 17
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats 15
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 15
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 14
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 13
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH 13
Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion 13
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis 10
SerpinB3 administration protects liver against ischemia-reperfusion injury 9
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 9
Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management 8
MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats 2
Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries 1
Totale 2.555
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020287 75 93 13 6 0 8 6 5 1 40 37 3
2020/2021116 6 5 3 5 0 20 18 23 13 12 9 2
2021/2022325 2 3 4 3 7 6 4 26 5 11 101 153
2022/20231.207 138 112 12 136 59 128 1 58 489 12 49 13
2023/2024480 78 54 23 24 39 83 49 30 1 20 31 48
Totale 2.555